LeMaitre Vascular, Inc. (LMAT)
| Market Cap | 1.27B |
| Revenue (ttm) | 134.70M |
| Net Income (ttm) | 23.98M |
| Shares Out | 20.55M |
| EPS (ttm) | 1.16 |
| PE Ratio | 54.24 |
| Forward PE | 48.08 |
| Dividend | $0.40 |
| Dividend Yield | 0.63% |
| Trading Day | June 21 |
| Last Price | $62.92 |
| Previous Close | $61.61 |
| Change ($) | 1.31 |
| Change (%) | 2.13% |
| Day's Open | 62.19 |
| Day's Range | 61.77 - 63.64 |
| Day's Volume | 93,655 |
| 52-Week Range | 23.57 - 63.64 |
BURLINGTON, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Hea...
BURLINGTON, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it received CE marks under the European Medical De...
BURLINGTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Co...
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and 0.95%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 75.00% over the past year to $0.28, which bea...
BURLINGTON, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2021 results and announced an $0.11/share quarterly...
BURLINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in May.
Bull Of The Day: LeMatire Vascular (LMAT)
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BURLINGTON, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2021 financial results on Thursday, April 29, 2021, aft...
Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.
New Strong Buy Stocks for April 8th
BURLINGTON, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 20th Annual Needham Virtual H...
Bridget Ross brings extensive experience in MedTech development and services; Joins advisory board of healthcare, logistics, capital markets and innovation leaders VANCOUVER, BC, March 23, 2021 /PRNewsw...
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
LeMaitre (LMAT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 47.83% over the past year to $0.34, whic...
BURLINGTON, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2020 results and announced an $0.11/share quarterly ...
BURLINGTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in four upcoming investor conferences.
BURLINGTON, Mass., Jan. 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2020 financial results on Thursday, February 25, 2021, ...
BURLINGTON, Mass., Dec. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in January.
The LeMaitre's corporate health partly depends on how much its sales reps can do to overcome current blocks, and how soon the pandemic ends.
LeMaitre has posted a strong quarter compounded by successful acquisition activity YTD, with little OPEX tied into profits in Q3. Management has widened the capital structure to be more debt inclusive, ...
Here are five top-ranked liquid stocks, Winnebago Industries, (WGO), Shutterstock (SSTK), Logitech (LOGI), Ituran Location and Control (ITRN), and LeMaitre Vascular (LMAT), that investors can snap up fo...
Here are four top-ranked liquid stocks, Winnebago Industries (WGO), Shutterstock (SSTK), Logitech (LOGI), and LeMaitre Vascular (LMAT), that investors can snap up for a winning portfolio.
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen U.S. Small Company Growth Composite Portfolio r...
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference o...
BURLINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in November.
LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q3 2020 Results - Earnings Call Transcript
LeMaitre (LMAT) delivered earnings and revenue surprises of 76.19% and 13.11%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of LeMaitre Vascular (NASDAQ:LMAT) moved higher by 7.5% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 48.00% year over year to $0.3...
BURLINGTON, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2020 results and announced a $0.095/s...
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BURLINGTON, Mass., Oct. 09, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2020 financial results on Thursday, October 29, 2020, af...
To increase the likelihood of unearthing high-quality companies, Benjamin Graham, the pioneer of value investing, recommended screening the market for stocks with a current ratio of more than 2 and high...
To increase the likelihood of unearthing high-quality companies, Benjamin Graham, the pioneer of value investing, recommended screening the market for stocks with a current ratio of more than 2 and high...
LeMaitre Vascular is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q2 2020 Results - Earnings Call Transcript
LeMaitre (LMAT) delivered earnings and revenue surprises of 440.00% and 59.48%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
BURLINGTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2020 results and announced a $0.095...
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BURLINGTON, Mass., July 10, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2020 financial results on Thursday, July 23, 2020, af...
BURLINGTON, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that it has acquired the business and assets of Artegraft, Inc. for $90.0 million, including $72.5...
MSA Safety, Fresnius Medical Care, and LeMaitre Vascular are well-priced stocks on the rise with solid dividends.
An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.
LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q1 2020 Results - Earnings Call Transcript
LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and -2.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
About LMAT
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the ... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date Oct 19, 2006 |
| CEO George LeMaitre | Employees 386 |
| Stock Exchange NASDAQ | Ticker Symbol LMAT |
Financial Performance
In 2020, LMAT's revenue was $129.37 million, an increase of 10.35% compared to the previous year's $117.23 million. Earnings were $21.22 million, an increase of 18.32%.
Analyst Forecasts
According to 5 analysts, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is 59.80, which is a decrease of -4.96% from the latest price.